Takeda Pharmaceutical Company Limited (NYSE:TAK) posted a second-quarter 2025 adjusted net profit of 201.6 billion Japanese yen (approximately $1.31 billion).The company reported earnings per American Depositary Share (EPADS) of 43 cents, missing analyst expectations of 44 cents. However, in yen, earnings per share declined 4.5$7.52 billion (1.18 trillion yen), missing the consensus estimates of $8.08 billion.Also Read: Takeda Taps Nabla Bio’s Generative ...